Micropore Technologies

Micropore Technologies is a private, revenue-generating platform company that has developed a patented, membrane-based particle engineering system. Its core value proposition is enabling the 'right first time' manufacturing of complex emulsions and particles for drug delivery with reduced waste, energy, and simplified scalability. The company is transitioning from an early-stage proof-of-concept entity into a commercial-stage provider, as evidenced by recent CEO appointment, global distributor partnerships, and sales of its Pathfinder™ systems to major biopharma players like Samsung Biologics.

Patented membrane-based emulsification and encapsulation technology for scalable, reproducible manufacturing of micro- and nanoparticles (e.g., LNPs, liposomes, PLGA microspheres).

Micropore competes with providers of traditional high-shear homogenization equipment (e.g., SPX Flow, GEA) and specialized nano-formulation systems from companies like Büchi or Microfluidics Corp. Its key differentiation is the membrane-based approach, which claims superior control, scalability, and gentleness for sensitive payloads.